Soligenix
SNGX
$0.32
Share price
-10.00%
Change (1 day)
-56.25%
Change (1 year)
Categories
Soligenix (SNGX) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $7.29 M
According to Soligenix's latest financial reports the company's total liabilities are $7.29 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Soligenix - Total liabilities on balance sheet (from 2001 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $16.75 M | 3.74% |
| 2021-12-31 | $16.14 M | -0.01% |
| 2020-12-31 | $16.14 M | 155.6% |
| 2019-12-31 | $6.31 M | 50.02% |
| 2018-12-31 | $4.21 M | 30.39% |
| 2017-12-31 | $3.22 M | 12.55% |
| 2016-12-31 | $2.86 M | -61.25% |
| 2015-12-31 | $7.4 M | 4.18% |
| 2014-12-31 | $7.1 M | -29.17% |
| 2013-12-31 | $10.03 M | 769.61% |
| 2012-12-31 | $1.15 M | -19.45% |
| 2011-12-31 | $1.43 M | -25.02% |
| 2010-12-31 | $1.91 M | 57.91% |
| 2009-12-31 | $1.21 M | -12.67% |
| 2008-12-31 | $1.38 M | 16.1% |
| 2007-12-31 | $1.19 M | -52.55% |
| 2006-12-31 | $2.51 M | 36.37% |
| 2005-12-31 | $1.84 M | -11.5% |
| 2004-12-31 | $2.08 M | 106.9% |
| 2003-12-31 | $1 M | -35.12% |
| 2002-12-31 | $1.55 M | -88.64% |
| 2001-12-31 | $13.67 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $101.94 B | 1,398,334.30% | 🇺🇸 USA |
 Pfizer PFE | $128.53 B | 1,763,093.74% | 🇺🇸 USA |
 Sanofi SNY | $57.61 B | 790,200.70% | 🇫🇷 France |
 Onconova Therapeutics ONTX | $12.15 M | 66.76% | 🇺🇸 USA |
 Athersys ATHX | $43.82 M | 501.14% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $35.23 B | 483,164.08% | 🇮🇱 Israel |
 Emergent BioSolutions
EBS | $1.13 B | 15,533.72% | 🇺🇸 USA |